ENLV

Enlivex Therapeutics Ltd.

3.39 USD
+0.18 (+5.61%)
Last updated
This page is just a preview of the data found in TrendSpider’s full version

Enlivex Therapeutics Ltd. stock is up 24.18% since 30 days ago. The next earnings date is Mar 15, 2024. The company has had above-average volume in the last 30 days. Its seasonality going into this month shows a chance of a red month, as 30% of the previous 9 March’s closed higher than February.

About Enlivex Therapeutics Ltd.

Enlivex Therapeutics Ltd. operates as a clinical stage immunotherapy company. It is developing Allocetra, an off-the-shelf cell therapy designed to reprogram macrophages into homeostatic state.